CN107543923A - Detect the kit and its detection method of avian leukosis virus A/B/J subgroup specific antibodies - Google Patents

Detect the kit and its detection method of avian leukosis virus A/B/J subgroup specific antibodies Download PDF

Info

Publication number
CN107543923A
CN107543923A CN201710730963.0A CN201710730963A CN107543923A CN 107543923 A CN107543923 A CN 107543923A CN 201710730963 A CN201710730963 A CN 201710730963A CN 107543923 A CN107543923 A CN 107543923A
Authority
CN
China
Prior art keywords
microballoon
acceptor
donor
kit
avian leukosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710730963.0A
Other languages
Chinese (zh)
Other versions
CN107543923B (en
Inventor
孙刚
李秀梅
张加勇
杨志
徐佳
王芳
汪淼
张俊峰
吕园园
杨二霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luoyang Modern Biotechnology Research Institute Co Ltd
Heilongjiang Animal Disease Prevention And Control Center
Original Assignee
Luoyang Modern Biotechnology Research Institute Co Ltd
Heilongjiang Animal Disease Prevention And Control Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luoyang Modern Biotechnology Research Institute Co Ltd, Heilongjiang Animal Disease Prevention And Control Center filed Critical Luoyang Modern Biotechnology Research Institute Co Ltd
Priority to CN201710730963.0A priority Critical patent/CN107543923B/en
Publication of CN107543923A publication Critical patent/CN107543923A/en
Application granted granted Critical
Publication of CN107543923B publication Critical patent/CN107543923B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to the kit and its detection method of detection avian leukosis virus A/B/J subgroup specific antibodies, belong to biology field, the kit includes luminous microwell plate, sealed membrane, acceptor microballoon I, acceptor microsphere Ⅱ, donor microballoon, calibration object and analysis buffer;Avian leukosis virus A/B subgroup His cENV albumen is marked on the acceptor microballoon I, avian leukosis virus J subgroup His gp85 albumen is marked on acceptor microsphere Ⅱ;Donor microballoon marks rabbit-anti chicken secondary antibody.Detection is that the sample serum of collection is pre-processed first, and then acceptor microballoon I, acceptor microsphere Ⅱ, donor microballoon and sample serum are added on luminous microwell plate on request, optical signal value is detected under 680nm exciting lights.The detection to avian leukosis virus A/B/J specific antibodies is the method achieve, simple to operate without washing, detection is sensitive, and specificity and stability are stronger.

Description

Detect kit and its detection of avian leukosis virus A/B/J subgroup specific antibodies Method
Technical field
The invention belongs to biology field, is related to Animal diseases detection, in particular it relates to detect avian leukosis virus The kit and its detection method of A/B/J subgroup specific antibodies.
Background technology
Avian leukosis refers to as caused by Retroviridae A type retrovirus fowl c-type retrovirus group with fowl Various transmissible tumor diseases in class hematopoietic tissue based on some cell component hyperplasias.It is white with fowl lymphatic Blood disease, erythroblast property leukaemia and myeloblastosis are relatively conventional, pass through two kinds of sides of vertical transmission and horizontal transmission Formula is widely current in the chicken group of countries in the world, causes chicken death, becomes thin, anaemia, retarded growth, while causes body to be resisted Power declines and immunosupress, is to endanger one of principal disease of aviculture.Chicken infected avian leukosis virus (ALV) group is main It is divided into six subgroups of A, B, C, D, E, J, wherein A, B subgroup strain gene order has very high homology, has similar disease Malicious characteristic.A, B, C, D and J subgroup are exogenous that E subgroups mainly exist in the form of provirus, are endogenic.A, B is sub- Group is more typical in chicken group, and C, D subgroup are more rare, and J subgroups are a kind of new avian leukosis virus subgroups.
The generation of China's A/B/J subgroup avian leucosis is fairly common, and clinical case mass-sends exhibition from initial commercial broiler To commodity egg, local breeder flock and other poultry, and along with oncogenicity enhancing and the generation of tumor multiplicity.Research is aobvious Show, high infection rate, high incidence is presented in the A/B/J subgroup avian leucosis poison in China, and early infection is universal, morbidity age in days substantially carries Before, the features such as mixed infection is multiple/take place frequently, and host range extension, tumour spectrum expand, and pathological change complicates, to supporting for China Fowl industry causes huge loss.For this, foreign countries take strict cut-out vertical transmission and isolate the offspring being uninfected by and raise Foster control techniques, from 1987, the large-scale breeder company of international developed country was just announced exogenous avian leukosis later Poison purifies.Because purification cycle is long, cost is high, also fail to effectively implement at present in China, can only by early diagnosis, in time Superseded infected chicken purifies population, and therefore, fast and accurately diagnostic method is particularly important in the sick preventing and treating.Except root Outside according to tentative diagnosis such as clinical symptoms, pathological changes, making a definite diagnosis for avian leukosis typically relies primarily on pathogeny detection, conventional inspection Survey method has the detection methods such as Virus Isolation, indirect immunofluorescence assay and ELISA, wherein, Virus Isolation is uncomfortable Conjunction detects to a large amount of samples;The characteristics of indirect immunofluorescence assay is to need fluorescence microscope, is operationally had certain Limitation;Although ELISA is adapted to the detection of extensive sample, operating process is cumbersome, time-consuming, and testing result goes out frequently The situation that existing false positive or viral recessiveness can not detect, and not can determine that virus subtype.
AlophaScreen(Amplified Luminscent Proximity Homogeneous Assay Screen) Technology is a kind of homogeneous detection method for being applied to analyte based on effect close between particulate and particulate, and AlophaLISA It is then the homogeneous detection method for having similarity with classic ELISA technology in AlophaScreen technical foundation, we are referred to as For homogeneous chemistry luminescence technology.The core of AlophaLISA methods be donor (photosensitive particulate) and acceptor (luminous particle) both The particulate that diameter is about 200nm.Mutually it is coupled in two kinds of microparticle surfaces and biomolecule (antibody or antigen protein), each particulate table Face can cover hundreds and thousands of individual biomolecule, can capture testing molecule.After particulate is irradiated by 680nm laser, donor table Oxygen in solution (AlophaLISA reaction solutions) will be converted into singlet oxygen by the sensitising agent in face.Singlet oxygen is in the solution Propagation distance be about 200nm, if the distance between donor and acceptor are less than 200nm, singlet oxygen is with regard to that can diffuse to acceptor Particulate, light-sensitive compound in acceptor just can and singlet oxygen chemically react, wherein Eu3+Complex just produces high level It is luminous.On the contrary, if the distance between luminous particle and photosensitive particulate are more than 200nm, free oxygen can not diffuse to luminous particle, There will be no the generation of optical signal.AlophaLISA homogeneous reactions are namely based on principles above, if being coated on two kinds of particulate tables The biomolecule in face is the distance between the two kinds of particulates that just furthered in the presence of interaction, produces optical signal.By to optical signal Intensity detection, to judge object to be measured is whether there is in actually detected sample.Although being based on this principle, AlophaLISA technologies exist Lung cancer, hepatitis or hand-foot-and-mouth disease etc. many-side has applied, but on avian leukosis virus detection of specific antibody there has been no It is related to, in view of principle in itself and does not have actual operation, the otherness between detectable substance in addition can not between detection architecture Use is indiscriminately imitated, detection efficiency and detection quality how is improved on this basis, forms a set of effective standards system, be allowed to It can in practice be widely used, be still a very important problem.
The content of the invention
In view of the above-mentioned problems, the present invention provides a kind of reagent for detecting avian leukosis virus A/B/J subgroup specific antibodies Box, changing kit can realize to being detected while avian leukosis virus A/B/J specific antibodies, simple to operate without washing, Detect sensitive.
A kind of homogeneous chemistry luminescence reagent box for detecting avian leukosis virus A/B/J subgroup specific antibodies, including it is luminous Microwell plate, sealed membrane, acceptor microballoon I, acceptor microsphere Ⅱ, donor microballoon, calibration object and analysis buffer;
Avian leukosis virus A/B subgroup His-cENV albumen is marked on the acceptor microballoon I, the white blood of fowl is marked on acceptor microsphere Ⅱ The viral J subgroups His-gp85 albumen of disease;The donor microballoon marks rabbit-anti chicken secondary antibody;
The labeling process of the acceptor microballoon I, acceptor microsphere Ⅱ or donor microballoon is realized by the following method:Will be to be marked Thing is placed in centrifuge tube, is added phosphate buffer, centrifugation, washing and suspension, is added MES buffer solutions after blotting supernatant, then Sequentially add purified label, sodium cyanoborohydride solution and Tween-20,2-8 DEG C of 40~48h of lucifuge revolving reaction Afterwards, 37 DEG C of stirring 1h terminating reactions of CMO lucifuges are added;Supernatant is removed in centrifugation, adds HEPES buffer solution to be resuspended, and supernatant is removed in centrifugation, adds Liquid is preserved, acceptor microballoon I, acceptor microsphere Ⅱ or the donor microballoon of coupling label is made;
Calibration object is formulated by the sterling antibody extracted in the positive standard serum that is mixed into from more parts of high level serum;
The analysis buffer is 50mmol/L, pH7.4 Tris-HCl buffer solutions, wherein being 0.8% containing mass fraction Bovine serum albumin(BSA) that NaCl, mass fraction are 1%, the casein that mass fraction is 0.1%, 0.1% surfactant S9, The Qula that volume fraction is 0.1% leads to the Proclin-300 that -100, volume fraction is 0.05%.
Further, the donor microballoon is mark rabbit-anti chicken secondary antibodyDonor microballoon.
Further, the acceptor microballoon I is the AlphaPlex of mark His-cENV albumenTM645 microballoons;Acceptor microballoon II is mark His-gp85 AlphaPlexTM545 microballoons.
Further, the labeling process of the acceptor microballoon I, acceptor microsphere Ⅱ or donor microballoon is real by the following method Existing:20mg/mL thing to be marked is placed in centrifuge tube, 0.1mol/L, pH8.0 are added into every 0.2mL thing to be marked Phosphate buffer 1 mL, centrifugation, washing and suspend repeatedly for 3~5 times, blot the MES buffer solutions that supernatant adds 0.2mL, then The purified labels of 1~3mg/mL of 0.2mg~0.6mg concentration are added, it is 400~500mmol/L to add 8~12uL concentration Sodium cyanoborohydride solution and Tween-20 that 12.5uL volume fractions are 1%, after 2-8 DEG C of 40~48h of lucifuge revolving reaction, Add 37 DEG C of stirring 1h terminating reactions of 10uL CMO lucifuges;Supernatant is removed in centrifugation, adds 50mmol/L pH7.4 HEPES buffer solution 0.5mL is resuspended, and supernatant is removed in centrifugation, adds and preserves liquid, and the acceptor microballoon I, acceptor microsphere Ⅱ or donor that coupling label is made are micro- Ball;
Further, it is described to preserve the Tris-HCl buffer solutions that liquid is 50mmol/L, pH7.4, wherein including 6.05g/L's Tris, 10g/L trehalose, 10g/L glucose, 30g/L mannitol, 20g/L bovine serum albumin(BSA), 5g/L dried meat ammonia Acid and the Proclin-300 that volume fraction is 0.1%.
Further, the calibration object is made by following methods:50 parts of high level serum after testing is hybridly prepared into Positive standard serum, 10000rpm/min centrifugation 30min, then through affinitive layer purification, collect sterling antibody, sterling antibody is used Ampere bottle is dispensed and freezes to form freeze-dried powder, and freeze-dried powder is configured into 6 calibration object concentration with analysis buffer:0ng/mL、 10ng/mL, 40ng/mL, 160ng/mL, 640ng/mL and 2560ng/mL.
The present invention also provides a kind of side of the kit detection avian leukosis A/B/J subgroup specific antibodies described in utilization Method, comprise the following steps:
Step 1: the collection and preservation of clinical samples:Take without anti-coagulants vacuum blood collection tube collection chicken venous whole sample, 37 DEG C 2h is placed, then placed overnight in 2~8 DEG C, the serum of precipitation is suctioned out, 3000rpm/min centrifugation 5min, take supernatant to dispense In EP pipes and blood sampling date and identifier are indicated, sample serum is made;If the sample serum same day uses, 2~8 are placed directly in In DEG C refrigerator;If the next day use, -20 DEG C of freezen protectives;
Step 2: the acceptor microballoon I prepared, acceptor microsphere Ⅱ and donor microballoon are respectively added into 100 μ L in luminous microwell plate, Then the μ L of sample serum 20 are added, are well mixed, 37 DEG C of incubation 20min, then excite lower detection not in the light that wavelength is 680nm With the signal light value of subgroup specific antibody.
Further, the concentration of acceptor microballoon I is 0.015mg/mL;The concentration of acceptor microsphere Ⅱ is 0.020mg/mL;For The concentration of body microballoon is 0.030mg/mL.
Beneficial effect:
The present invention utilizes homogeneous chemistry luminescence technology, and envelope protein is coupled on acceptor microballoon, rabbit-anti chicken is marked on donor microballoon Secondary antibody, antigen or antibody protein are coupled on microballoon using the system of original creation, in the coupling mark system of albumen and microballoon, PH of buffer, solution concentration and dosage, reaction time and temperature etc. can all have an impact to coupling labeling process, and the present invention uses Different buffer solution washing microballoons, increases its surface group activity, in being reacted with label, sequentially adds sodium cyanoborohydride Solution and Tween-20, prevent the active group of microsphere surface from aoxidizing, or other chemical reactions occur, be passivated active group, Lose activity, or the serious reduction of activity;Coupling time and reaction condition are controlled, the colleague of reaction rate is being improved, is avoiding sending out Raw albumen autoimmunity syndrome, improve coupling amount.Washed again with buffer solution after completion of the reaction, reduce non-covalent adsorption, at utmost Coupling efficiency is improved, increases the homogeneity, sensitivity and specificity of coupled complex, and then determine microballoon in specific antibody High sensitivity and high efficiency in detection, furthermore, preserve trehalose, glucose, mannitol, the bovine serum albumin added in liquid In vain, coordinative role between proline and Proclin-300, the stability and specificity of coupling material are improved, can be fast exactly Speed detects target substance, the effect of having given full play of kit.The kit can also be realized to avian leukosis virus A/B/J Detected while specific antibody, and the antibody of these three subgroups, convenient and swift, efficiency can be distinguished according to the flashlight of detection Height, and without washing, simple to operate, detection is sensitive.Meanwhile open a kind of detection avian leukosis virus specific antibody and resist The new way of body, form a set of effective detection architecture.
Detected using the kit, avian leukosis A/B subgroups positive serum and the dilution of 256 times of dilution can be detected 512 times of J subgroup positive serums, sensitiveness are higher;15 parts of poultry diease positive serums are detected, the testing result of all samples It is all negative, shows the present invention and other poultry diease serum no cross reactions, there is good specificity, and to avian leukosis poison A/ The detection of B/J subgroup positive serums, luminous signal is very strong, illustrates there is good reactivity.In addition, carried out using the kit Detection, preferably, stability is strong for repeatability, can be preserved 12 months at 2-8 DEG C.The kit can be used for avian leukosis poison A/B/ J subgroups antibody carries out quantitative detection.
Brief description of the drawings
Fig. 1 is pUC19-cENV gene recombination plasmid double digestion qualification result electrophoretograms;Wherein, left side is using restricted The genetic fragment that restriction endonuclease EcoRI, XhoI double digestion pUC19-gp85 is obtained, right side DL10000Marker;
Fig. 2 is pUC19-gp85 gene recombination plasmid double digestion qualification result electrophoretograms;Wherein, 1 is to use restriction enzyme EcoRI, XhoI double digestion pUC19 empty plasmids, 2 be to be obtained using restriction enzyme EcoRI, XhoI double digestion pUC19-gp85 Genetic fragment, M is 1kb DNA Ladder;
Fig. 3 is recombinant expression protein cENV rear SDS-PAGEs before purification;Wherein, M is protein Marker in figure, and 1 is Induction bacterium bacterium solution precipitates, and 2 be supernatant, and 3 be great expression albumen precipitation, and 4 be result after great expression protein purification;
Fig. 4 is recombinant expression protein gp85 rear SDS-PAGEs before purification;Wherein, M is protein Marker in figure, and 1 is Induction bacterium bacterium solution precipitates, and 2 be supernatant, and 3 be great expression albumen precipitation, and 4 be result after great expression protein purification;
Fig. 5 is Western blot methods detection cENV recombinant protein result figures;
Fig. 6 is Western blot methods detection gp85 recombinant protein result figures.
Embodiment
Following examples or test example are used to illustrate the present invention, are not intended to limit protection scope of the present invention, are not carrying on the back In the case of from spirit of the invention and essence, the modifications or substitutions done to the inventive method, step or condition belong to this hair Bright protection domain.
Unless otherwise specified, chemical reagent used is conventional commercial reagent in embodiment or test example, technology hand used The conventional meanses that section is well known to those skilled in the art.
Main agents, instrument or consumptive material used and its source are as follows in the present invention:
Main agents:
MES (MES), cyaniding sodium borohydride (NaBH3CN), the salt of carboxymethyl azanol half (CMO), 4- hydroxyethyl piperazines Ethyl sulfonic acid (HEPES) and Prolcin-300 are purchased from Sigma-Aldrich companies;
Tween-20 is purchased from Pierce companies;
AlphaPlexTM6 45 and AlphaPlexTM545 are purchased from Perkin Elmer companies of the U.S.;
Albumen pre-dyed Marker, Taq polymerase, restriction enzyme Nco I and Xho I are purchased from Thermo companies;
T4DNA ligase, dNTP, DNA Marker, IPTG, pUC19 carrier are purchased from doctor's biotechnology (Beijing) limited public affairs of precious day Department;
Plasmid extraction kit is purchased from OMEGA companies;
His tag antibodies are Beijing Quanshijin Biotechnology Co., Ltd's product.Main consumptive material and instrument:
Light excites Chemiluminescence Apparatus to be purchased from Perkin Elmer companies of the U.S.;
Ultrahigh speed freezing self-balancing centrifuge Osterode D-37520 are purchased from German Thermo fisher companies;
Ultraviolet specrophotometer TU-1900 is purchased from Beijing Puxi General Instrument Co., Ltd.
The expression and preparation of the avian leukosis poison A/B/J subgroup envelope proteins of test example 1
According to the gene order for the ALV-A/B/J subgroup envelope proteins delivered in NCBI GenBank, with reference to right both at home and abroad The progress of ALV-A/B/J subgroups, the envelope protein antigen epitope genes sequence for representing popular strain is filtered out, is recombinated A/B subgroup envelope protein cENV gene order 1244bp, its nucleotide sequence SEQ ID NO:Shown in 1;Recombinant J subgroup cyst membrane egg White gp85 gene order 1024bp, its nucleotide sequence SEQ ID NO:Shown in 3.For ease of follow-up test, expanded by PCR, Make the 5 of A/B subgroups envelope protein cENV gene orders and J subgroup envelope protein gp85 gene orders, the end position of digestion containing NcoI Point, 3 ' ends restriction enzyme site containing XhoI.Obtained cENV gene orders and gp85 gene orders are respectively connecting to pUC19 carriers On.Sequencing, after checking is correct, by pET32a (+) and the above-mentioned pUC-19 cloning vectors for being connected to target gene respectively with limitation Property restriction endonuclease Nco I and Xho I carry out double digestion 60min under 37 DEG C of water bath conditions, after 1% agarose gel electrophoresis, Glue reclaim large fragment after pET32a (+) double digestion, target gene fragment is reclaimed after pUC-19 cloning vector double digestions.Double digestion As a result as depicted in figs. 1 and 2.Will reclaim obtain large fragment and target gene fragment in 22 DEG C overnight connection, wherein with cENV The linked system of target gene fragment is:PET32a (+) carrier 1uL, cENV genetic fragments 1.5uL, ddH2O 20uL, T4DNA connects Enzyme 1.5uL, 10 × Green Buffer 3uL, the common 27uL of cumulative volume are met, obtains connection product pET32a-cENV recombinant plasmids; Linked system with gp85 target gene fragments is:PET32a (+) carrier 1uL, gp85 genetic fragments 1.5uL, ddH2O 20uL, T4DNA ligase 1.5uL, 10 × Green Buffer 3uL, the common 27uL of cumulative volume, obtain connection product pET32a-gp85 weights Group plasmid.
Connection product pET32a-cENV recombinant plasmids and pET32a-gp85 recombinant plasmids are conventionally turned respectively Enter 0.1%CaCl2In the competence bacterium BL21 of preparation, it is coated in the LB solid mediums containing ampicillin, 37 DEG C It is incubated overnight, next day picking single bacterium colony, shakes bacterium, extraction plasmid sends to sequencing after carrying out double digestion identification, confirms wherein have such as SEQ ID NO:1 and SEQ ID NO:Sequence shown in 3, it is seen that the restructuring cENV genes and gp85 genes of acquisition respectively into Work(is cloned into pET32a-cENV recombinant plasmids and pET32a-gp85 recombinant plasmids.
Positive E. coli BL21 bacterium containing recombinant plasmid are inoculated in into the solid containing ampicillin (Amp) resistance to train Support in base, after 37 DEG C are incubated overnight, take 3~4 single bacterium colonies to be inoculated in the LB fluid nutrient mediums containing Amp, 37 DEG C of concussions (250rpm/min) is cultivated to OD600=0.8, it is extremely final concentration of to add IPTG (isopropyl-beta D-thio galactopyranoside) 1mmol/L, 37 DEG C are continued culture 4 hours, are obtained fusion protein His-cENV and His-gp85 with HIS labels, are cultivated simultaneously The recombinant plasmid transformed BL21 bacterium not induced are as negative control.The amino acid sequence SEQ of the A/B subgroups His-cENV albumen ID NO:Shown in 02, the amino acid sequence SEQ ID NO of J subgroup His-gp85 albumen:Shown in 4.The albumen of expression is through SDS- PAGE and Western-blot identifications, as a result as shown in Figure 3 and Figure 4.
The engineering bacteria bacterium solution of culture is collected, 6000rpm/min centrifugation 10min, supernatant is abandoned, precipitates and weighed with PBS Suspension, GuNTA-0Buffer and PMSF is then added in re-suspension liquid and uses Ultrasonic Cell Disruptor ultrasonication BL21 bacteriums at low temperature, 120W, work 2s, interval 3s, 100 circulations of ultrasound;Then ultrasonication bacterium solution is transferred in 50ml centrifuge tubes, trim, 4 DEG C, 12000r/min is centrifuged 10 minutes, takes supernatant, -20 DEG C of preservations;Affinity chromatography is carried out to cracking thalline with Ni-NTA Purification Resins, Sample is added in chromatographic column, and flow velocity 12ml/h collects penetrating component.Chromatography is eluted with the GuNTA-60Buffer of 5 times of NTA volumes, Flow velocity 12ml/h, collect eluent.With the dialysis eluent of 0.5mol/LNaCl and 20mmol/L Tris-HCl solution 24 hours, Avian leukosis cENV albumen and gp85 albumen after purification carries out SDA-PAGE and Western-blot testing goal purity of protein Up to 97%.Obtained albumen is by Bradford methods measure protein content, and the packing of 2ml centrifuge tubes, -80 DEG C save backup.
The purification step of recombinant protein is as follows:
Precipitation is resuspended with the cleaning solution I of 9 times of volumes in the precipitation that above-mentioned centrifugation obtains, after standing 5min, 8000rpm, 4 DEG C, 15min, abandon supernatant.Precipitation is resuspended with the cleaning solution II of 9 times of volumes, after standing 5min, 8000rpm, 4 DEG C, 15min, abandons supernatant, Retain precipitation.Precipitation is resuspended with the cleaning solution II I of 9 times of volumes, after standing 5min, 8000rpm, 4 DEG C, 15min, abandons supernatant, protects Stay precipitation.Add 4-10mL lysates according to 100mL bacterium solutions, 4 DEG C overnight.8000rpm, 4 DEG C, 15min.Supernatant is taken, is as purified Albumen.
Preparation of reagents method described in inclusion body purification:
1st, bacterium re-suspension liquid (250mL):PBS (NaCl 2g, KCl 0.05g, Na2HPO40.36g, KH2PO40.06g), 1mmol/L EDTA;
2nd, solution I (500mL):500mmol/L Tris-HCl (PH=6.0), 50mmol/L NaCl, 50mmol/L EDTA;
3rd, solution II (250mL):Solution I, 1mol/L urea;
4th, solution III (250mL):Solution I, 2mol/L urea;
5th, solubilization of inclusion bodies liquid (250mL):Solution I, 8mol/L urea.
The His-cENA albumen and His-gp85 albumen obtained using above-mentioned purifying is coated with elisa plate respectively, and use is enzyme-linked Immunosorbent adsorption test (ELISA) detects the biological activity of the albumen.Examined with His tag antibodies and IDEXX detection kits It is that positive chicken serum is positive control to survey avian leukosis poison A/B/J antibody, and healthy SFP chicken serums are negative control, and HRP is marked Sheep anti-mouse igg, sheep anti-chicken IgG ELIAS secondary antibody use to specifications.As a result positive control and the OD values with negative control are shown Ratio is big by 2.1, illustrates that the albumen has good biological activity and antigenicity.
Wherein, ELISA is comprised the following steps that:
1st, it is coated with:Take and purified recombinant protein, optium concentration, coating reaction are diluted to 0.05MpH9.6 carbonate buffer solution Plate, 100ul/ holes, 4 DEG C overnight;
2nd, wash:The coating buffer in ELISA Plate is got rid of, each hole is filled it up with PBST (PBS, 0.05%Tween-20), is stored at room temperature 3min, PBST is discarded, wash 3 times, 3min/ times, pat dry;
3rd, close:Each hole adds confining liquid (2%BSA), 200ul/ holes, puts 4 DEG C overnight, after closing, pats dry;
4th, it is loaded:Coating plate, 100ul/ holes are added after serum to be detected is pressed into gradient dilution, while sets up yin and yang attribute serum pair According to.Put 37 DEG C of incubators and be incubated 1h, wash 3 times, 3min/ times, pat dry;
5th, sheep anti-mouse igg, sheep anti-chicken IgG ELIAS secondary antibody is marked to press 1 HRP with PBST:2000 dilutions, 100ul/ holes, put 37 DEG C Incubator is incubated 1h, washs 3 times, 3min/ times, pats dry;6th, develop the color:Use TMB one-components nitrite ion (TIANGEN Products) Coating plate is added by 100ul/ holes, lucifuge colour developing 15min adds terminate liquid (2MH under the conditions of 37 DEG C2SO4) color development stopping;7th, with enzyme-linked Immune detector surveys its and detects the OD values in each hole in wavelength 450nm, and negative control OD450 values are N, positive control OD450 values For P.If P/N>2.1 are judged to the positive.
The preparation of the acceptor microballoon of test example 2 and donor microballoon
Take AlphaPlexTM645 acceptor microballoon (20mg/mL) 0.2mL are placed in 1.5mL EP centrifuge tubes, add 0.1mol/L PH 8.0 phosphate buffer 1 mL, centrifuge washing are suspended 3 times, and each centrifugal force 16000g/min is centrifuged 15 minutes, is blotted Reset and add into 0.2mL MES buffer solutions, then add the recombinant protein that 1~3mg/mL of 0.3mg~0.6mg concentration has purified high activity Avian leukosis virus A/B subgroup His-cENV, it is molten to add the sodium cyanoborohydride that 8~12uL concentration is 400~500mmol/L Liquid and 12.5uL 1%Tween-20, after 2-8 DEG C of 40~48h of revolving reaction of lucifuge, it is anti-to add the 37 DEG C of stirrings of 10uL CMO lucifuges Answer 1h terminating reactions.By 4 DEG C of the acceptor microballoon marked, 13000g/min centrifugation 30min, supernatant is removed with pipettor, is added The HEPES buffer solution 0.5mL for entering 50mmol/L, pH7.4 is resuspended, and shakes suspension bottom of the tube acceptor microballoon;Repeat the above steps from The heart 2 times, the preservation liquid for adding 50mmol/L, pH7.4 are stand-by.
Take AlphaPlexTM545 acceptor microballoon (20mg/mL) 0.2mL are placed in 1.5mL EP centrifuge tubes, are added 0.1mol/L, pH 8.0 phosphate buffer 1 mL, centrifuge washing suspend 3 times, and each centrifugal force 16000g/min centrifuges 15 points Clock, blots supernatant and adds 0.2mL MES buffer solutions, then adds 1~2mg/mL of 0.2mg~0.5mg concentration and has purified high activity Recombinant protein avian leukosis virus J subgroup His-gp85 albumen, add 8~12uL concentration be concentration be 400~ 500mmol/L sodium cyanoborohydride solution and 12.5uL 1%Tween-20, after 2-8 DEG C of 40~48h of revolving reaction of lucifuge, add Enter 37 DEG C of stirring reaction 1h terminating reactions of 10uL CMO lucifuges.4 DEG C of the acceptor microballoon marked, 13000g/min are centrifuged 30min, supernatant is removed with pipettor, the HEPES buffer solution 0.5mL for adding 50mmol/L, pH7.4 is resuspended, concussion suspension pipe Bottom acceptor microballoon;Repeat the above steps centrifugation 2 times, and it is stand-by to add 0.2mL 50mmol/L, pH7.4 preservation liquid.
Take aldehyde radicalDonor microballoon (20mg/mL) 0.2mL is placed in 1.5mL EP centrifuge tubes, is added 0.02mol/L pH7.6 phosphate buffer 1 mL, centrifuge washing suspend 3 times, and each centrifugal force 16000g/min centrifuges 15 points Clock, blots supernatant and adds 0.2mL MES buffer solutions, then adds 1~2mg/mL of 0.4mg~0.6mg concentration and has purified high activity Rabbit-anti chicken secondary antibody, add 8~12uL concentration be concentration be 400~500mmol/L sodium cyanoborohydride solution and After 12.5uL 1%Tween-20,2-8 DEG C of 40~48h of revolving reaction of lucifuge, 37 DEG C of stirring reaction 1h of 10uL CMO lucifuges are added Terminating reaction.By 4 DEG C of the acceptor microballoon marked, 13000g/min centrifugation 30min, supernatant is removed with pipettor, added 50mmol/L, pH7.4 HEPES buffer solution 0.5mL are resuspended, and shake suspension bottom of the tube acceptor microballoon;Repeat the above steps centrifugation 2 Secondary, the preservation liquid for adding 50mmol/L, pH7.4 is stand-by.
The preparation of the HEPES buffer solution:HEPES 5.96g and bovine serum albumin(BSA) (BSA) 5g are weighed, adds water 800mL Dissolving, adds 5mL Tween-20s, adds water to be settled to 1L.
The preservation liquid is 50m mol/L, pH7.4 Tris-HCl buffer solutions:Tris 6.05g are weighed, add water 800mL Dissolving, adjust pH to 7.4;Add trehalose 10g, glucose 10g, mannitol 30g, BSA 20g, proline 5g, Proclin-300 1mL, after dissolving plus water is settled to 1L.
The preparation of described 0.1mol/L, pH 8.0 phosphate buffer:Weigh Na2HPO4·12H2O 33.9g and NaH2PO40.731g, add water 800mL to dissolve, add 0.5mL Tween-20s, add water to be settled to 1L.
The preparation of described 0.02mol/L, pH7.6 phosphate buffer:Weigh Na2HPO4·12H2O 5.8g、NaH2PO4 0.496g and NaCl 8g, add water 800mL to dissolve, add 0.5mL Tween-20s, add water to be settled to 1L.
The preparation of the MES buffer solutions:MES 21.3g are weighed, add 800mL distilled water to dissolve, are adjusted with 10mol/L NaOH PH value is settled to 1L to 6.0.
The homogeneous chemistry luminescence detection kit of the avian leukosis A/B/J subgroup specific antibodies of test example 3 assembles
The homogeneous chemistry luminescence detection kit of avian leukosis A/B/J subgroup specific antibodies, including luminous microwell plate, sealing Film, acceptor microballoon, donor microballoon, calibration object and analysis buffer;It is sub- that the acceptor microballoon includes coupling avian leukosis virus A/B The AlphaPlex of group's His-cENV albumenTM645 acceptor microballoons and coupling avian leukosis virus J subgroup His-gp85 albumen AlphaPlexTM545 acceptor microballoons;The donor microballoon is mark rabbit-anti chicken secondary antibodyDonor microballoon;Institute State as the Tris-HCl buffer solutions that analysis buffer is 50mmol/L, pH7.4, wherein containing the NaCl that mass fraction is 0.8%, Casein that bovine serum albumin(BSA) that mass fraction is 1%, mass fraction are 0.1%, 0.1% surfactant S9, volume integral Number leads to the Proclin-300 that -100, volume fraction is 0.05% for 0.1% Qula;The luminous microwell plate is that 96 holes light Microwell plate (Perkin Elmer companies of the U.S.);(U.S. PerkinElmer is public using TopSeal-A sealed membranes for the sealed membrane Department).
The calibration object is made by following methods:50 parts of high level serum after testing is hybridly prepared into positive criteria blood Clearly, 10000rpm/min centrifuges 30min, then through affinitive layer purification, collects sterling antibody, sterling antibody is dispensed with ampere bottle And freeze and form freeze-dried powder, freeze-dried powder is configured to 6 calibration object concentration with analysis buffer:0ng/mL、10ng/mL、40ng/ ML, 160ng/mL, 640ng/mL and 2560ng/mL.
Assemble and finish, kit saves backup in -20 DEG C.
The homogeneous chemistry luminescence detection kit detection avian leukosis A/B/J subgroup specificity of the present invention of test example 4 is anti- The condition optimizing of body
(1) acceptor microballoon and the optimal dilution ratio of donor microballoon
Using Checkerboard titration method, avian leukosis virus A/B subgroups His-cENV AlphaPlexTM645 acceptor microballoons and fowl are white The viral J subgroups His-gp85 of blood disease AlphaPlexTM545 acceptor microballoons all set respectively 0.005mg/mL, 0.010mg/mL, 0.015mg/mL, 0.020mg/mL, 0.025mg/mL, 0.030mg/mL totally 6 concentration, mark rabbit-anti chicken secondary antibodyDonor microballoon sets 0.010mg/mL, 0.020mg/mL, 0.030mg/mL, 0.040mg/mL totally 4 concentration, surveys Determine result and optimal dilution ratio is determined with signal/blank ratio (Signal/Background, S/B) and four parameter curves. The final AlphaPlex for determining labelled protein avian leukosis virus A/B subgroups His-cENVTM645 acceptor microballoon optium concentrations are 0.015mg/ml, labelled protein avian leukosis virus J subgroups His-gp85 AlphaPlexTM545 acceptor microballoon optium concentrations For 0.020mg/ml, rabbit-anti chicken secondary antibody is markedDonor microballoon optium concentration is 0.030mg/ml.
(2) reaction temperature and time
10min, 20min, 30min, 40min, 50min, 60min will be set as the reaction time, reaction temperature sets 25 DEG C and 37 DEG C, according to S/B values, selection S/B value highest times and most short temperature and time, the acceptor that will be prepared in luminous microwell plate Microballoon and donor microballoon respectively add 100 μ L, then add the μ L of sample serum 20, are well mixed, by the temperature that sets in advance and when Between dereaction, then light excite Chemiluminescence Apparatus read signal value.As a result select 37 DEG C incubation 20min, be optimum temperature and Incubation time.
(3) selection of most suitable analysis buffer
Choose following 4 kinds of buffer solutions:HEPES buffer solution, PBS, MES buffer solutions, Tris buffer solutions, using S/B as excellent Change standard.Final choice S/B value highests analysis buffer is 50mmol/L, pH7.4 Tris-HCl buffer solutions, wherein containing Casein that bovine serum albumin(BSA) that NaCl that mass fraction is 0.8%, mass fraction are 1%, mass fraction are 0.1%, The Qula that 0.1%S9, volume fraction are 0.1% leads to the Proclin-300 that -100, volume fraction is 0.05%
The method that 5 kit of the present invention of test example detects avian leukosis A/B/J subgroup specific antibodies
The method of kit detection avian leukosis A/B/J subgroup specific antibodies of the present invention, comprises the following steps:
Step 1: the collection and preservation of clinical samples:Take without anti-coagulants vacuum blood collection tube collection chicken venous whole sample, 37 DEG C 2h is placed, then placed overnight in 2~8 DEG C, the serum of precipitation is suctioned out, 3000rpm/min centrifugation 5min, take supernatant to dispense In EP pipes and blood sampling date and identifier are indicated, sample serum is made;If the sample serum same day uses, 2~8 are placed directly in In DEG C refrigerator;If the next day use, -20 DEG C of freezen protectives.
Step 2: the acceptor microballoon prepared and donor microballoon are respectively added into 100 μ L in luminous microwell plate, then add The μ L of sample serum 20, it is well mixed, 37 DEG C of incubation 20min, then excites Chemiluminescence Apparatus to read luminous value in light.
Step 3: the operating process detected according to homogeneous chemistry luminescence reagent box described in step 1 and step 2, will be prepared The calibration object of six kinds of concentration is measured, and the parameter fitting of acquired results four, which returns, to be calculated, and obtains regression equation and calibration object dosage Response curve.The luminous value and response curve of the sample serum determined according to step 2, calculate specific antibody in sample serum Dose value.
The master of the method for 6 kit of the present invention of test example detection avian leukosis virus A/B/J subgroup specific antibodies Want index
(1) sensitiveness
The strong positive serum specimen for by 3 parts being respectively avian leukosis A subgroups, B subgroups and J subgroups makees gradient dilution 1:8、1:16、1: 32、1:64、1:128、1:256、1:512、1:1024, detected with detection method of the present invention, as a result such as table 1 below institute Show.30 parts of positive sample serum is chosen, is tested with virus purification, detection method of the present invention and external import kit (IDEXX) determine, as a result understand simultaneously, the result that three kinds of detection methods detect positive serum sample known to 30 parts compares coincidence rate For 100%.
Table 1:Kit sensitivity Detection
Detection method of the present invention can detect the avian leukosis A subgroups and B subgroups of 256 times of dilution it can be seen from upper table 1 Strong positive serum, the lowest dose level value of the specific antibody of detectable A subgroups is 22ng/mL, detectable B subgroups The lowest dose level value of specific antibody is 26ng/mL;Detection method of the present invention can detect the avian leukosis of 512 times of dilution J subgroups positive serum by force, the lowest dose level value of the specific antibody of detectable J subgroups is 12ng/mL.
(2) it is specific
Buy Dutch 15 parts of poultry diease specific criteria positive serum samples of GD companies:Poultry infectious bursal disease (IBD), fowl are infected Property bronchitis (IBV, Beaudette strain), ewcastle disease (NDV), avian encephalomyelitis (AE), the poor blood factor of fowl (CAV), infectiousness Laryngotracheitis (ILT), synovia mycoplasma (MS), bird flu (AIV, 0126 plant), reovirus (REO), avian infectious branch gas Guan Yan (IBV, Mass strain), aviadenovirus (FAV, Phelp strain), aquatic bird/bird pox virus (FPV), fowl subtract egg virus (EDS-76), Frustrate blood and mycoplasma (MG) and paramyxovirus (APMV).It also have purchased 3 parts of avian leukosis A subgroups, B subgroups and J subgroup standards in addition Positive serum sample
Above-mentioned 15 kinds of poultry diease specific criteria positive serums and ALV-A/B/J subgroups standard positive serum are all carried out 1:8 dilutions, The method for quantitatively detecting antibody with homogeneous chemistry luminescence reagent box of the present invention is detected, specific detection data such as following table Shown in 2.
Table 2:Kit specific detection
There is upper table 2 to understand, 15 parts of poultry diease specific criteria blood serum samples of the detection method detection of kit of the present invention, institute The testing result for having sample is all negative, shows the present invention and other poultry diease serum no cross reactions, has good specificity. Avian leukosis poison A/B/J subgroup standard positive serums are detected, luminous signal is very strong, illustrates there is good reactivity, Neng Gouyong To carry out quantitative detection to avian leukosis poison A/B/J subgroups antibody.
(3) precision
Take avian leukosis A subgroups positive 1 part of serum specimen, B subgroups 1 part of positive serum specimen and J subgroups positive serum specimen 1 by force by force by force Part.By these three serum samples, everyone is repeated 20 times experiment to two laboratory technicians (A and B), calculates the measured result coefficient of variation (CV), As a result show:A laboratory technician measures result CV average percents for 20 times as 6.28%;B laboratory technician measures result CV average hundred for 20 times Point than being respectively less than 10% for 7.44%, CV percentages, illustrate it is reproducible, it is as a result reliable and stable.
(4) stability
Mark avian leukosis virus A/B subgroups His-cENV prepared by present invention AlphaPlexTM645 acceptor microballoons, mark Remember avian leukosis virus J subgroups His-gp85 AlphaPlexTM545 acceptor microballoons, mark rabbit-anti chicken secondary antibodyDonor microballoon, and analysis buffer are placed in 2-8 DEG C and preserved 0,3,6,9,12 month, are then established with the present invention The quality-control product (PC, IBD, IBV, NDV, REO, AIV, SPF) that is preserved to this laboratory of homogeneous chemistry luminescence method detected, see The Sensitivity and Specificity variation tendency of the homogeneous chemistry luminescence method is examined, assesses the stability of this method, as a result such as table 3 below institute Show.
Table 3:Stabilization of kit detects
There is upper table 3 to understand, the main agents used in kit of the present invention preserve 12 months at 2-8 DEG C, its sensitiveness, spy Different in nature result does not almost change, illustrates that the kit had very strong stability in 12 months.
SEQUENCE LISTING
<110>Heilongjiang Province's animal epidemic prevention and control centre, Luoyang Co., Ltd of modern biotechnology research institute
<120>Detect the kit and its detection method of avian leukosis virus A/B/J subgroup specific antibodies
<130> 1
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 1148
<212> DNA
<213>Avian leukosis virus
<400> 1
ccatgggtac acccttgctg ccaacgagag ttaattatat tctcattatt ggtgtcctgg 60
tcttgtgtga ggttacgggg gtgagagctg atgttcactt actcgagcag ccaggtggca 120
gcacggattt ctgcctctct acacagggcg gcagcacctc cccttttcag acatgtttga 180
taggtatccc gtcccctatt ggcggtagca aggggtacgt ctctggtaat tgcaccgcct 240
tgggtggcag ctatcggaag gtttcatgct tgttgttaaa gctgaatgtt tccctgttgg 300
acgagccagg tggcagcgaa ctacaactgt taggttccca gtctctccct ggaggcagct 360
acggtagtcc ggcgggcgtt tacggcggca gccaagttac acacatcctc ttgactgacg 420
gtggcagccc gtttacagta gtgacagcag gtggcagcgg aagtgaatat tgcggtgcat 480
atggctacgg aggcagcgtc agtggatgtt gcggggaatc aatcacgatt ctcccaccag 540
gggcgtgggt cgacggtggt agcaaaccaa aggcgctacc acccggaatt ttcctcattt 600
gtggggatgg cggaagcccc agtcgtccgg tagggggccc ctgctattta ggaaaactta 660
ccatgttagg cggcagcata ctcgccaatt cgggcggtag ccataaacga agcgtcacac 720
acctggatga tacaggcggc agctcagatg aagtaacgct ttggggtgga ggcagcgcaa 780
gaatctttgc atctatctta gctccggggg tagcagctgc gcaagcctta agaggtggca 840
gcagactagc ctgttggtcc gttaaacagg ctggcggtag caccacatca ctcctcgggg 900
acttattgga tgatgtcacg agtattcgac acgcggtcct gcagaaccga ggtggcagca 960
ttgacttctt gcttctggct cacggccatg gctgtgagga cattgctgga atgtgttgtt 1020
tcaatctcag tggcggcagc gaatgggccg ttcatttgct aaaaggacta cttttggggc 1080
tggtagttat cttgctgcta gtagtatgcc tgccttgctt tttgcaattc gtatctagta 1140
gcctcgag 1148
<210> 2
<211> 382
<212> PRT
<213>E. coli bl21
<400> 2
Met Gly Thr Pro Leu Leu Pro Thr Arg Val Asn Tyr Ile Leu Ile Ile
1 5 10 15
Gly Val Leu Val Leu Cys Glu Val Thr Gly Val Arg Ala Asp Val His
20 25 30
Leu Leu Glu Gln Pro Gly Gly Ser Thr Asp Phe Cys Leu Ser Thr Gln
35 40 45
Gly Gly Ser Thr Ser Pro Phe Gln Thr Cys Leu Ile Gly Ile Pro Ser
50 55 60
Pro Ile Gly Gly Ser Lys Gly Tyr Val Ser Gly Asn Cys Thr Ala Leu
65 70 75 80
Gly Gly Ser Tyr Arg Lys Val Ser Cys Leu Leu Leu Lys Leu Asn Val
85 90 95
Ser Leu Leu Asp Glu Pro Gly Gly Ser Glu Leu Gln Leu Leu Gly Ser
100 105 110
Gln Ser Leu Pro Gly Gly Ser Tyr Gly Ser Pro Ala Gly Val Tyr Gly
115 120 125
Gly Ser Gln Val Thr His Ile Leu Leu Thr Asp Gly Gly Ser Pro Phe
130 135 140
Thr Val Val Thr Ala Gly Gly Ser Gly Ser Glu Tyr Cys Gly Ala Tyr
145 150 155 160
Gly Tyr Gly Gly Ser Val Ser Gly Cys Cys Gly Glu Ser Ile Thr Ile
165 170 175
Leu Pro Pro Gly Ala Trp Val Asp Gly Gly Ser Lys Pro Lys Ala Leu
180 185 190
Pro Pro Gly Ile Phe Leu Ile Cys Gly Asp Gly Gly Ser Pro Ser Arg
195 200 205
Pro Val Gly Gly Pro Cys Tyr Leu Gly Lys Leu Thr Met Leu Gly Gly
210 215 220
Ser Ile Leu Ala Asn Ser Gly Gly Ser His Lys Arg Ser Val Thr His
225 230 235 240
Leu Asp Asp Thr Gly Gly Ser Ser Asp Glu Val Gln Leu Trp Gly Gly
245 250 255
Gly Ser Ala Arg Ile Phe Ala Ser Ile Leu Ala Pro Gly Val Ala Ala
260 265 270
Ala Gln Ala Leu Arg Gly Gly Ser Arg Leu Ala Cys Trp Ser Val Lys
275 280 285
Gln Ala Gly Gly Ser Thr Thr Ser Leu Leu Gly Asp Leu Leu Asp Asp
290 295 300
Val Thr Ser Ile Arg His Ala Val Leu Gln Asn Arg Gly Gly Ser Ile
305 310 315 320
Asp Phe Leu Leu Leu Ala His Gly His Gly Cys Glu Asp Ile Ala Gly
325 330 335
Met Cys Cys Phe Asn Leu Ser Gly Gly Ser Glu Trp Ala Val His Leu
340 345 350
Leu Lys Gly Leu Leu Leu Gly Leu Val Val Ile Leu Leu Leu Val Val
355 360 365
Cys Leu Pro Cys Phe Leu Gln Phe Val Ser Ser Ser Leu Glu
370 375 380
<210> 3
<211> 1087
<212> DNA
<213>Avian leukosis virus
<400> 3
ccatgggtac acccttgctg ccaacgagag ttaattatat tctcattatt ggtgtcctgg 60
tcttgtgtga ggttacgggg gtgagagctg atgttcactt actcgagcag ccaggtggca 120
gcacggattt ctgcctctct acacagggcg gcagcacctc cccttttcag acatgtttga 180
taggtatccc gtcccctatt ggcggtagca aggggtacgt ctctggtaat tgcaccttgg 240
gtggcagcta tcggaagatt tcatgcttgt tgttaaagct gaatgtttcc ctgttggacg 300
agccaggtgg cagcgaacta caactgttag gttcccagtc tctccctgga ggcagctacg 360
gcagtccggc gggcgtttac ggcggcagcc aagttacaca catcctcttg actgacggtg 420
gcagcccgtt tacagtagtg acagcaggtg gcagcggaag tgaatattgc ggtgcatatg 480
gctacggagg cagcgtcagt ggatgttgcg gggaatcaat cacgattctc ccaccagggg 540
cgtgggtcga cggtggtagc aaaccaaagg cgctaccacc cggaattttc ctcatttgtg 600
gggatggcgg aagccccagt cgtccggtag ggggcccctg ctatttagga aaacttacca 660
tgttaggcgg cagcatactc gccaattcgg gcggtagcca taaacgaagc gtcacacacc 720
tggatgatac aggcggcagc tcagatgaag tacagctttg gggtggaggc agcgcaagaa 780
tctttgcatc tatcttagct ccgggggtag cagctggcgg tagcaccaca tcactcctcg 840
gggacttatt ggatgatgtc acgagtattc gacacgcggt cctgcagaac cgaggtggca 900
gcattgactt cttgcttctg gctcacggcc atggctgtga ggacattgct ggaatgtgtt 960
gtttcaatct cagtggcggc agcgaatggg ccgttcattt gctaaaagga ctacttttgg 1020
ggctggtagt tatcttgctg ctagtatgcc tgcttgcttt ttgcaattcg tatctagtag 1080
cctcgag 1087
<210> 4
<211> 383
<212> PRT
<213>E. coli bl21
<400> 4
Met Gly Thr Pro Leu Leu Pro Thr Arg Val Asn Tyr Ile Leu Ile Ile
1 5 10 15
Gly Val Leu Val Leu Cys Glu Val Thr Gly Val Arg Ala Asp Val Ile
20 25 30
Leu Leu Glu Gln Pro Gly Gly Ser Thr Asp Phe Cys Leu Ser Thr Gln
35 40 45
Gly Gly Ser Thr Ser Pro Phe Gln Thr Cys Leu Ile Gly Ile Pro Ser
50 55 60
Pro Ile Gly Gly Ser Lys Gly Tyr Val Ser Gly Asn Cys Thr Ala Leu
65 70 75 80
Gly Gly Ser Tyr Arg Lys Val Ser Cys Leu Leu Leu Lys Leu Asn Val
85 90 95
Ser Leu Leu Asp Glu Pro Gly Gly Ser Glu Leu Gln Leu Leu Gly Ser
100 105 110
Gln Ser Leu Pro Gly Gly Ser Tyr Gly Ser Pro Ala Gly Val Tyr Gly
115 120 125
Gly Ser Gln Val Thr His Ile Leu Leu Thr Asp Gly Gly Ser Pro Phe
130 135 140
Thr Val Val Thr Ala Gly Gly Ser Gly Ser Glu Tyr Cys Gly Ala Tyr
145 150 155 160
Gly Tyr Gly Gly Ser Val Ser Gly Cys Cys Gly Glu Ser Ile Thr Ile
165 170 175
Leu Pro Pro Gly Ala Trp Val Asp Gly Gly Ser Lys Pro Lys Ala Leu
180 185 190
Pro Pro Gly Ile Phe Leu Ile Cys Gly Asp Gly Gly Ser Pro Ser Arg
195 200 205
Pro Val Gly Gly Pro Cys Tyr Leu Gly Lys Leu Thr Met Leu Gly Gly
210 215 220
Ser Ile Leu Ala Asn Ser Gly Gly Ser His Lys Arg Ser Val Thr His
225 230 235 240
Leu Asp Asp Thr Gly Gly Ser Ser Asp Glu Val Gln Leu Trp Gly Gly
245 250 255
Gly Ser Ala Arg Ile Phe Ala Ser Ile Leu Ala Pro Gly Val Ala Ala
260 265 270
Ala Leu Gln Ala Leu Arg Gly Gly Ser Arg Leu Ala Cys Trp Ser Val
275 280 285
Lys Gln Ala Gly Gly Ser Thr Thr Ser Leu Leu Gly Asp Leu Leu Asp
290 295 300
Asp Val Thr Ser Ile Arg His Ala Val Leu Gln Asn Arg Gly Gly Ser
305 310 315 320
Ile Asp Phe Leu Leu Leu Ala His Gly His Gly Cys Glu Asp Ile Ala
325 330 335
Gly Met Cys Cys Phe Asn Leu Ser Gly Gly Ser Glu Trp Ala Val His
340 345 350
Leu Leu Lys Gly Leu Leu Leu Gly Leu Val Val Ile Leu Leu Leu Val
355 360 365
Val Cys Leu Pro Cys Phe Leu Gln Phe Val Ser Ser Ser Leu Glu
370 375 380

Claims (8)

  1. A kind of 1. homogeneous chemistry luminescence reagent box for detecting avian leukosis virus A/B/J subgroup specific antibodies, it is characterised in that: Including microwell plate, sealed membrane, acceptor microballoon I, acceptor microsphere Ⅱ, donor microballoon, calibration object and the analysis buffer of lighting;
    Avian leukosis virus A/B subgroup His-cENV albumen is marked on the acceptor microballoon I, the white blood of fowl is marked on acceptor microsphere Ⅱ The viral J subgroups His-gp85 albumen of disease;The donor microballoon marks rabbit-anti chicken secondary antibody;
    The labeling process of the acceptor microballoon I, acceptor microsphere Ⅱ or donor microballoon is realized by the following method:Will be to be marked Thing is placed in centrifuge tube, is added phosphate buffer, centrifugation, washing and suspension, is added MES buffer solutions after blotting supernatant, then Sequentially add purified label, sodium cyanoborohydride solution and Tween-20,2-8 DEG C of 40~48h of lucifuge revolving reaction Afterwards, 37 DEG C of stirring 1h terminating reactions of CMO lucifuges are added;Supernatant is removed in centrifugation, adds HEPES buffer solution to be resuspended, and supernatant is removed in centrifugation, adds Liquid is preserved, acceptor microballoon I, acceptor microsphere Ⅱ or the donor microballoon of coupling label is made;
    Calibration object is formulated by the sterling antibody extracted in the positive standard serum that is mixed into from more parts of high level serum;
    The analysis buffer is 50mmol/L, pH7.4 Tris-HCl buffer solutions, wherein being 0.8% containing mass fraction Bovine serum albumin(BSA) that NaCl, mass fraction are 1%, the casein that mass fraction is 0.1%, 0.1% surfactant S9, body The Qula that fraction is 0.1% leads to the Proclin-300 that -100, volume fraction is 0.05%.
  2. 2. kit as claimed in claim 1, it is characterised in that:The donor microballoon is mark rabbit-anti chicken secondary antibody AlphaScreen donor microballoons.
  3. 3. kit as claimed in claim 1, it is characterised in that:The acceptor microballoon I is mark His-cENV albumen The microballoons of AlphaPlex 645;Acceptor microsphere Ⅱ is the mark His-gp85 microballoons of AlphaPlex 545.
  4. 4. kit as claimed in claim 1, it is characterised in that:The acceptor microballoon I, acceptor microsphere Ⅱ or donor microballoon Labeling process is realized by the following method:20mg/mL thing to be marked is placed in centrifuge tube, waits to mark to every 0.2mL Remember the phosphate buffer 1 mL that 0.1mol/L, pH 8.0 is added in thing, centrifugation, wash and suspend 3~5 times repeatedly, blot supernatant 0.2mL MES buffer solutions are added, the purified labels of 1~3mg/mL of 0.2mg~0.6mg concentration is then added, adds 8 The Tween-20,2- that the sodium cyanoborohydride solution and 12.5uL volume fractions that~12uL concentration is 400~500mmol/L are 1% After 8 DEG C of 40~48h of lucifuge revolving reaction, 37 DEG C of stirring 1h terminating reactions of 10uL CMO lucifuges are added;Supernatant is removed in centrifugation, adds 50mmol/L pH7.4 HEPES buffer solution 0.5mL is resuspended, and supernatant is removed in centrifugation, adds and preserves liquid, and coupling label is made Acceptor microballoon I, acceptor microsphere Ⅱ or donor microballoon.
  5. 5. the kit as described in claim 1 or 4, it is characterised in that:The liquid that preserves is 50mmol/L, pH7.4 Tris-HCl buffer solutions, wherein the trehalose of Tris, 10g/L comprising 6.05g/L, 10g/L glucose, 30g/L sweet dew Alcohol, 20g/L bovine serum albumin(BSA), 5g/L proline and volume fraction are 0.1% Proclin-300.
  6. 6. kit as claimed in claim 1, it is characterised in that:The calibration object is made by following methods:By 50 parts of warps The high level serum of detection is hybridly prepared into positive standard serum, 10000rpm/min centrifugation 30min, then through affinitive layer purification, Sterling antibody is collected, sterling antibody ampere bottle is dispensed and freezed to form freeze-dried powder, is prepared freeze-dried powder with analysis buffer Into 6 calibration object concentration:0ng/mL, 10ng/mL, 40ng/mL, 160ng/mL, 640ng/mL and 2560ng/mL.
  7. 7. utilize the kit detection avian leukosis A/B/J subgroup specific antibodies such as claim 1-4 or 6 as described in any one Method, it is characterised in that:Comprise the following steps:
    Step 1: the collection and preservation of clinical samples:Take without anti-coagulants vacuum blood collection tube collection chicken venous whole sample, 37 DEG C 2h is placed, then placed overnight in 2~8 DEG C, the serum of precipitation is suctioned out, 3000rpm/min centrifugation 5min, take supernatant to dispense In EP pipes and blood sampling date and identifier are indicated, sample serum is made;If the sample serum same day uses, 2~8 are placed directly in In DEG C refrigerator;If the next day use, -20 DEG C of freezen protectives;
    Step 2: the acceptor microballoon I prepared, acceptor microsphere Ⅱ and donor microballoon are respectively added into 100 μ L in luminous microwell plate, Then the μ L of sample serum 20 are added, are well mixed, 37 DEG C of incubation 20min, then excite lower detection not in the light that wavelength is 680nm With the signal light value of subgroup specific antibody.
  8. 8. method as claimed in claim 7, it is characterised in that:The concentration of acceptor microballoon I is 0.015mg/mL;Acceptor microsphere Ⅱ Concentration be 0.020mg/mL;The concentration of donor microballoon is 0.030mg/mL.
CN201710730963.0A 2017-08-23 2017-08-23 Kit for detecting avian leukosis virus A/B/J subgroup specific antibody and detection method thereof Active CN107543923B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710730963.0A CN107543923B (en) 2017-08-23 2017-08-23 Kit for detecting avian leukosis virus A/B/J subgroup specific antibody and detection method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710730963.0A CN107543923B (en) 2017-08-23 2017-08-23 Kit for detecting avian leukosis virus A/B/J subgroup specific antibody and detection method thereof

Publications (2)

Publication Number Publication Date
CN107543923A true CN107543923A (en) 2018-01-05
CN107543923B CN107543923B (en) 2020-05-19

Family

ID=60958893

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710730963.0A Active CN107543923B (en) 2017-08-23 2017-08-23 Kit for detecting avian leukosis virus A/B/J subgroup specific antibody and detection method thereof

Country Status (1)

Country Link
CN (1) CN107543923B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109444414A (en) * 2018-09-10 2019-03-08 珠海国际旅行卫生保健中心 Using the method and corresponding composition, kit of AlphaLISA detection dengue virus
CN109633164A (en) * 2018-12-14 2019-04-16 迪瑞医疗科技股份有限公司 A kind of thyroglobulin antibody detection kit calibration object and its preparation process
CN109811064A (en) * 2019-04-02 2019-05-28 华南农业大学 One kind molecular labeling relevant to chicken J subgroup avian leucosis resistance and its application
CN110161232A (en) * 2018-02-11 2019-08-23 北京科美生物技术有限公司 Detect homogeneous immunological detection reagent box and its application of antiCCP antibody
CN110161248A (en) * 2018-02-11 2019-08-23 北京科美生物技术有限公司 Detect homogeneous immunological detection reagent box and its application of anti-Carp antibody
CN110261599A (en) * 2019-05-16 2019-09-20 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) A kind of ELISA kit and its application detecting A, B subgroup avian leucosis virus antibody
CN110736737A (en) * 2018-07-18 2020-01-31 博阳生物科技(上海)有限公司 microsphere composition for chemiluminescence detection and application thereof
CN110736734A (en) * 2018-07-18 2020-01-31 博阳生物科技(上海)有限公司 cTnI homogeneous phase chemiluminescence detection kit, detection method and device
CN110736739A (en) * 2018-07-18 2020-01-31 博阳生物科技(上海)有限公司 homogeneous phase chemiluminescence detection kit and application thereof
CN110981969A (en) * 2019-12-24 2020-04-10 长江大学 ALV-K ELISA kit and detection method thereof
WO2020252870A1 (en) * 2019-06-21 2020-12-24 北京科美生物技术有限公司 Homogeneous chemiluminescence detection method and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646913A (en) * 2002-04-10 2005-07-27 反应生物医学公司 Sensitive immunochromatographic assay
CN103472235A (en) * 2013-08-26 2013-12-25 河北省科学院生物研究所 Long-acting protein solution stabilizing agent
CN103837675A (en) * 2014-03-07 2014-06-04 常艳敏 Homogeneous luminescence immunoassay method for quantitatively analyzing multiple components simultaneously and kit used for method
CN102735833B (en) * 2012-07-09 2015-01-21 沃克(天津)生物科技有限公司 Thyroperoxidase antibody homogeneous-phase luminescent immunoassay kit and detection method thereof
CN104548087A (en) * 2014-12-26 2015-04-29 山东农业大学 Epitope vaccine for resisting A/B subgroup avian leucosis virus infection and preparation method and application of epitope vaccine
CN106442982A (en) * 2016-08-31 2017-02-22 扬州大学 Fowl leucovirus subgroup J specific antigenic polypeptide and application thereof
CN106932583A (en) * 2015-12-29 2017-07-07 北京大成生物工程有限公司 Human epidermal growth factor acceptor Her-2/neu immue quantitative detection reagent boxes and preparation method and application

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646913A (en) * 2002-04-10 2005-07-27 反应生物医学公司 Sensitive immunochromatographic assay
CN102735833B (en) * 2012-07-09 2015-01-21 沃克(天津)生物科技有限公司 Thyroperoxidase antibody homogeneous-phase luminescent immunoassay kit and detection method thereof
CN103472235A (en) * 2013-08-26 2013-12-25 河北省科学院生物研究所 Long-acting protein solution stabilizing agent
CN103837675A (en) * 2014-03-07 2014-06-04 常艳敏 Homogeneous luminescence immunoassay method for quantitatively analyzing multiple components simultaneously and kit used for method
CN104548087A (en) * 2014-12-26 2015-04-29 山东农业大学 Epitope vaccine for resisting A/B subgroup avian leucosis virus infection and preparation method and application of epitope vaccine
CN106932583A (en) * 2015-12-29 2017-07-07 北京大成生物工程有限公司 Human epidermal growth factor acceptor Her-2/neu immue quantitative detection reagent boxes and preparation method and application
CN106442982A (en) * 2016-08-31 2017-02-22 扬州大学 Fowl leucovirus subgroup J specific antigenic polypeptide and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘丽娜,等: "J亚群禽白血病病毒gp85基因的原核表达及间接ELISA方法建立", 《中国预防兽医学报》 *
吴艳,等: "AB亚群禽白血病病毒gp85蛋白的克隆表达及其单克隆抗体的制备", 《中国畜牧兽医学会禽病学分会第十五次学术研讨会论文集》 *
朱陈娟: "检测J亚群禽白血病病毒抗体的间接ELISA方法建立和针对gp85蛋白的单克隆抗体研制", 《中国优秀硕士学位论文全文数据库 农业科技辑》 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110161248A (en) * 2018-02-11 2019-08-23 北京科美生物技术有限公司 Detect homogeneous immunological detection reagent box and its application of anti-Carp antibody
CN110161248B (en) * 2018-02-11 2023-06-20 科美诊断技术股份有限公司 Homogeneous phase immunity detection kit for detecting anti-Carp antibody and application thereof
CN110161232B (en) * 2018-02-11 2023-02-28 科美诊断技术股份有限公司 Homogeneous phase immunoassay kit for detecting anti-CCP antibody and application thereof
CN110161232A (en) * 2018-02-11 2019-08-23 北京科美生物技术有限公司 Detect homogeneous immunological detection reagent box and its application of antiCCP antibody
CN110736737A (en) * 2018-07-18 2020-01-31 博阳生物科技(上海)有限公司 microsphere composition for chemiluminescence detection and application thereof
CN110736734A (en) * 2018-07-18 2020-01-31 博阳生物科技(上海)有限公司 cTnI homogeneous phase chemiluminescence detection kit, detection method and device
CN110736739A (en) * 2018-07-18 2020-01-31 博阳生物科技(上海)有限公司 homogeneous phase chemiluminescence detection kit and application thereof
CN109444414A (en) * 2018-09-10 2019-03-08 珠海国际旅行卫生保健中心 Using the method and corresponding composition, kit of AlphaLISA detection dengue virus
CN109633164A (en) * 2018-12-14 2019-04-16 迪瑞医疗科技股份有限公司 A kind of thyroglobulin antibody detection kit calibration object and its preparation process
CN109811064A (en) * 2019-04-02 2019-05-28 华南农业大学 One kind molecular labeling relevant to chicken J subgroup avian leucosis resistance and its application
CN109811064B (en) * 2019-04-02 2023-12-05 华南农业大学 Molecular marker related to avian leukosis resistance of chicken J subgroup and application thereof
CN110261599A (en) * 2019-05-16 2019-09-20 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) A kind of ELISA kit and its application detecting A, B subgroup avian leucosis virus antibody
CN110261599B (en) * 2019-05-16 2022-02-08 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) ELISA kit for detecting A, B subgroup avian leukosis virus antibody and application thereof
WO2020252870A1 (en) * 2019-06-21 2020-12-24 北京科美生物技术有限公司 Homogeneous chemiluminescence detection method and application thereof
CN110981969A (en) * 2019-12-24 2020-04-10 长江大学 ALV-K ELISA kit and detection method thereof

Also Published As

Publication number Publication date
CN107543923B (en) 2020-05-19

Similar Documents

Publication Publication Date Title
CN107543923A (en) Detect the kit and its detection method of avian leukosis virus A/B/J subgroup specific antibodies
CN110093356B (en) DNA sequence coding for African swine fever virus antigen, composition of antigen coded by DNA sequence and application of DNA sequence in immunological detection
EP1778880B1 (en) Methods and reagents for diagnosing hantavirus infection
CN111378018B (en) Test strip for detecting novel coronavirus antibody and preparation method and application thereof
CN111929433B (en) African swine fever virus antibody ELISA detection kit and preparation method thereof
CN113009153A (en) Magnetic particle chemiluminescence-based detection kit for neutralizing antibody of novel coronavirus and application thereof
CN113215107B (en) Time-resolved fluoroimmunoassay kit for detecting novel coronavirus and preparation method thereof
CN102731615A (en) Detection reagent and detection method for PRRSV
US20230358757A1 (en) Antigen for 2019 novel coronavirus and detection use thereof
CN111521816A (en) Time-resolved fluorescence immunochromatographic assay test strip for echinococcosis granulosus of cattle and preparation method thereof
CN108761077A (en) Poultry diease viral disease protein chip antibody assay kit and its preparation method and application
CN115873079B (en) Canine infectious hepatitis virus hexon protein antigen, truncated body and application thereof
CN108918869B (en) Application of fiber2 protein and recombinant protein thereof in detecting serum type 4 avian adenovirus antibody
CN106188248A (en) A kind of Epstein-Barr virus antigen preparation procedure and utilize the quick detection kit of detection Epstein-Barr virus antibody prepared by this antigen
CN113684189A (en) Novel chicken circovirus type 3 strain and detection system based on same
CN110240635B (en) Polypeptide for detecting newcastle disease virus antibody and ELISA detection kit thereof
CN107219365A (en) A kind of chemiluminescence detection kit based on foot and mouth disease virus 3B neoepitope Westerns
CN107163144A (en) Antibody and kit for detecting Serum Alpha Fetoprotein
CN109824766A (en) A kind of indirect ELISA testing kit using 4 type antibody of Fiber2 Protein Detection aviadenovirus
CN106279408B (en) Monoclonal antibody and antibody combination for resisting foot-and-mouth disease type O virus and application of monoclonal antibody and antibody combination in detection of virus antigen and antibody
CN113045673B (en) African swine fever virus antibody detection kit based on chimeric P54 epitope and application
CN111929438B (en) Quantum dot microsphere immunochromatography test strip for detecting African swine fever virus antibody and application thereof
CN113884674A (en) Mycoplasma bovis colloidal gold immunoassay test strip, preparation method and application thereof
CN113322268A (en) African swine fever virus p72 recombinant protein and colloidal gold immunochromatographic test paper constructed by same
CN108181476A (en) Test strips based on fluorescent micro-ball immune chromatography method detection avian leukosis virus and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant